Global Cancer Photodynamic Therapy Market and Cancer Photosensitisers Clinical Trial Outlook 2023 Report Download

Efficacy and safety of a therapeutic method has always been the prime concern during treatment of an ailment. Any therapeutic method that fulfills the above criteria has been deemed to be a successful procedure. Nonetheless, patients and health professionals not only seek the efficacy and safety of a treatment method, but also look into it being a non- invasive procedure involving minimal to no pain. It is evident that such a procedure would be a blockbuster therapeutic .This is what the Photodynamic Therapy (PDT) currently aims to do.

“Global Cancer Photodynamic Therapy Market and Cancer Photosensitisers Clinical Trial Outlook 2023” Report Highlight:

* Working Mechanism of the Photodynamic Cancer Therapy
Photosensitizer Delivery
* Anti-Tumor Activity of the Photodynamic Therapy
* Status of Various Cancer Treatments Using Photodynamic Therapy
* Promising Advances in the Photodynamic Therapy Segment
* Photodynamic Combinational Cancer Therapy
* Global Cancer Photosensitisers Clinical Pipeline by Company and Phase
* Marketed Cancer Photosensitisers Clinical Insight

Download Sample

For Report Sample Contact: neeraj@kuickresearch.com

Report Weblink: https://www.kuickresearch.com/report-global-cancer-photodynamic-therapy-market-and-cancer-photosensitisers-clinical-trial-outlook-2023.php

Table of Contents

1. An Introductory Insight into Photodynamic Cancer Therapy
1.1 Overview
1.2 History and Evolution of the Photodynamic Cancer Therapy

2. Photodynamic Therapy andndash; A Breakthrough in Modern Cancer Therapy
2.1 Dire Need for Photodynamic Therapy in Cancer Treatment andndash; An Insight into its promising features
2.2 Superiority of Photodynamic Cancer Therapy over Traditional Cancer Therapy Method

3. Working Mechanism of the Photodynamic Cancer Therapy- It’s Components and Their Role
3.1 Procedure for Photodynamic Therapy
3.2 Photosensitizers (PS) andndash; A Crucial Component of the Photodynamic Therapy
3.2.1 Classification of Photosensitizers
3.2.2 Desired Features of an Effective Photosensitizer Agent
3.2.3 Photosensitizers Currently Used in Photodynamic Therapy
3.3 Oxygen - The Vital Substrate in Photodynamic Therapy
3.4 Light Source - For Safe and Effective Activation of the Photosensitizer

4. Photosensitizer Delivery andndash; For Increased Efficacy of the Photdynamic Therapy
4.1 Organic Nano Particles Photosensitizer Delivery in Photo Dynamic therapy
4.2 Inorganic Nanocarrier of Photosensitizers in Photodynamic Therapy

5. Anti-Tumor Activity of the Photodynamic Therapy
5.1 Direct Tumor Photodynamic Therapy Damage
5.2 Vascular Damage
5.3 Inflammatory and Immune Response

6. Current Status of Various Cancer Treatments Using Photodynamic Therapy
6.1 Non-Melanoma Skin Cancer
6.2 Prostate Cancer
6.3 Breast Cancer
6.4 Brain Tumor
6.5 Lung Cancer
6.6 Head and Neck Cancer
6.7 Oral Lesions and Oesophageal Cancer
6.8 Cervical Cancer
6.9 Colorectal Cancer
6.10 Cancer of the Bile Duct and the Pancreas

7. Photodynamic Combinational Cancer Therapy- Overcoming Current Cancer Therapy Limitations

8. Recent and Promising Advances in the Photodynamic Therapy Segment
8.1 Intracellular “Activated” Two-Photon photodynamic Therapy for Breast Cancer
8.2 Gold Nano-Clusters: A New Nanotech Innovation for Photodynamic Therapy.
8.3 Photodynamic Therapy and Combinational Therapy using Microbial Adjuvants and Cytokines

9. Current Market Scenario of the Photodynamic Therapy and its Cognizance in the Oncology Segment
9.1 Global Photodynamic Therapy Market Analysis by Device and Essentials
9.2 Regional Analysis of the Photodynamic Therapy Market
9.2.1 North America
9.2.2 Europe
9.2.3 Asia Pacific
9.2.4 Latin America, Middle East and Africa

10. Favorable Factors for the Growth of Photodynamic Cancer Therapy Market
10.1 Rise in Global Cancer Incident
10.2 Increasing Awareness Regarding Photodynamic Therapy
10.3 Limitations and Failures of Existing Cancer Therapeutics
10.4 Advancement in Research and Development
10.5 Increasing Investment in the Photodynamic Therapy Segment
10.6 Presence of a Strong Clinical Pipeline
10.7 Approvals of the FDA

11. Challenges to the Photodynamic Therapy Market Growth
11.1 Technical and Scientific Limitations
11.2 Dominance of Conventional Therapeutics
11.3 Commercial Challenges
11.4 Patient Specific Issues
11.5 Side Effects Associated with the Photodynamic Therapy

12. Anticipation Regarding the Future of Photodynamic Cancer Therapy

13. Global Cancer Photosensitisers Clinical Pipeline by Company and Phase
13.1 Preclinical
13.2 Phase-I
13.3 Phase-I/II
13.4 Phase-II
13.5 Phase-III
13.6 Registered

14. Marketed Cancer Photosensitisers Clinical Pipeline by Company
14.1 Hexyl Aminolevulinate (Cevira, Cysview, Hexvix and Hexvix PDT)
14.2 Methyl Aminolevulinate (Metvix, Metvix PDT, Metvixia and Visonac)
14.3 Talaporfin (Aptocine, Aptocine, Aptocine and Litx)
14.4 Aminolevulinic Acid (Litx and Alaglio)
14.5 Aminolevulinic Acid (Alaglio, Effala, Gleolan and Gliolan)
14.6 Porfimer Sodium (Photobarr, Photofrin, Photofrin II and Photofrin PDT)
14.7 Methoxsalen Solution (UVADEX)
14.8 Temoporfin (Foscan)

15. Competitive Landscape
15.1 Theralase Technologies
15.2 Dusa Pharmaceuticals
15.3 Biofrontera AG
15.4 Soligenix
15.5 Coherent
15.6 Lumenis
15.7 Nanoprobes
15.8 PhotoMedex
15.9 Biolitec
15.10 Ambicare Health
15.11 Quest Pharma Tech
15.12 Photolitec

Kuick Research is a market research and analytics company that provides targeted information for critical decisions at business, product and service levels. We are quick, predictive and known by the recommendations we have made in the past. Our result-oriented research methodology offers understanding of multiple issues in a short period of time and gives us the capability to keep you full with loads of practical ideas. By translating research answers into strategic insight and direction, we not only rate the success potential of your products and/or services, but also help you identify the opportunities for growth in new demographies and find ways to beat competition.

Neeraj Chawla
neeraj@kuickresearch.com
KuicK Research
L29 - L34, First Floor
Block L,Connaught Place
New Delhi-110001
+91-11-47067990

This release was published on openPR.